Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Cirioni

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Travel Medicine|October 17, 1998
Cyclosporiasis in a traveler returning from South AmericaD Drenaggi, O Cirioni, A Giacometti, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteriaA Giacometti, O Cirioni, G Greganti, et al.
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell cultureA Giacometti, O Cirioni, F Barchiesi, et al.
European Journal of Epidemiology|July 22, 1999
Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohortsO Cirioni, A Giacometti, D Drenaggi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 30, 1999
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibioticsA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosaA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2000
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systemsA Giacometti, O Cirioni, F Barchiesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Irritable bowel syndrome in patients with Blastocystis hominis infectionA Giacometti, O Cirioni, A Fiorentini, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1994
Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosaA Giacometti, F M Siquini, O Cirioni, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Travel Medicine|October 17, 1998
Cyclosporiasis in a traveler returning from South AmericaD Drenaggi, O Cirioni, A Giacometti, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteriaA Giacometti, O Cirioni, G Greganti, et al.
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell cultureA Giacometti, O Cirioni, F Barchiesi, et al.
European Journal of Epidemiology|July 22, 1999
Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohortsO Cirioni, A Giacometti, D Drenaggi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 30, 1999
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibioticsA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosaA Giacometti, O Cirioni, F Barchiesi, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2000
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systemsA Giacometti, O Cirioni, F Barchiesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 12, 1999
Irritable bowel syndrome in patients with Blastocystis hominis infectionA Giacometti, O Cirioni, A Fiorentini, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis cariniiO Cirioni, A Giacometti, F Barchiesi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1994
Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosaA Giacometti, F M Siquini, O Cirioni, et al.
Pageof 6